These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 34919237)
1. Thrombotic microangiopathy in primary antiphospholipid syndrome is linked to stroke and less deep venous thrombosis. Freire de Carvalho J; Brandão Neto R; Skare T Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7369-7374. PubMed ID: 34919237 [TBL] [Abstract][Full Text] [Related]
2. Primary antiphospholipid syndrome with and without limb ischemia: A retrospective observational study. de Carvalho JF; Brandão Neto RA; Skare TL; Shoenfeld Y Lupus; 2023 Nov; 32(13):1486-1492. PubMed ID: 37852301 [TBL] [Abstract][Full Text] [Related]
3. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome]. Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190 [TBL] [Abstract][Full Text] [Related]
4. Influence of gender on the clinical and laboratory spectra of patients with primary antiphospholipid syndrome. de Carvalho JF Rheumatol Int; 2011 May; 31(5):647-50. PubMed ID: 20058014 [TBL] [Abstract][Full Text] [Related]
5. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study. Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203 [TBL] [Abstract][Full Text] [Related]
6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for arterial thrombosis in antiphospholipid syndrome. Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419 [TBL] [Abstract][Full Text] [Related]
8. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
9. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome. Kopytek M; Natorska J; Undas A Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587 [TBL] [Abstract][Full Text] [Related]
10. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study. Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381 [TBL] [Abstract][Full Text] [Related]
11. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production? de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747 [TBL] [Abstract][Full Text] [Related]
12. Primary antiphospholipid syndrome with and without Sneddon's syndrome. Caldas CA; de Carvalho JF Rheumatol Int; 2011 Feb; 31(2):197-200. PubMed ID: 20012621 [TBL] [Abstract][Full Text] [Related]
13. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome. da Silva Saraiva S; de Moraes Mazetto B; Quinteiro Tobaldine L; Pereira Colella M; Vinícius De Paula E; Annichinno-Bizzachi J; Andrade Orsi F Am J Hematol; 2017 Nov; 92(11):1163-1169. PubMed ID: 28762539 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome. Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of risk factors in development of thrombosis in patients with antiphospholipid syndrome]. Li R; Zhou YS; Jia Y; Li ZG Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):788-91. PubMed ID: 23073594 [TBL] [Abstract][Full Text] [Related]
16. Primary Antiphospholipid Syndrome with Livedo Reticularis is Linked to Female Sex and Stroke and Negatively Associated with Thyroid Disease. Carvalho JF; de Araujo RPC; Skare TL Curr Rheumatol Rev; 2022; 18(4):352-356. PubMed ID: 34784875 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome. Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012 [TBL] [Abstract][Full Text] [Related]
18. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study. Mustonen P; Lehtonen KV; Javela K; Puurunen M Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304 [TBL] [Abstract][Full Text] [Related]
19. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Galli M; Luciani D; Bertolini G; Barbui T Blood; 2003 Mar; 101(5):1827-32. PubMed ID: 12393574 [TBL] [Abstract][Full Text] [Related]
20. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome. Pasoto SG; Chakkour HP; Natalino RR; Viana VS; Bueno C; Lianza AC; de Andrade JL; Neto ML; Fuller R; Bonfa E Clin Rheumatol; 2012 Sep; 31(9):1331-8. PubMed ID: 22692396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]